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Intercalated diskThe precise spatial order of gap junctions at intercalated disks in adult ventricular myocardium is thought vital
for maintaining cardiac synchrony. Breakdown or remodeling of this order is a hallmark of arrhythmic disease
of the heart. The principal component of gap junction channels between ventricular cardiomyocytes is
connexin43 (Cx43). Protein–protein interactions and modiﬁcations of the carboxyl-terminus of Cx43 are key
determinants of gap junction function, size, distribution and organization during normal development and in
disease processes. Here, we review data on the role of proteins interacting with the Cx43 carboxyl-terminus in
the regulation of cardiac gap junction organization, with particular emphasis on Zonula Occludens-1. The
rapid progress in this area suggests that in coming years we are likely to develop a fuller understanding of the
molecular mechanisms causing pathologic remodeling of gap junctions. With these advances come the
promise of novel approach to the treatment of arrhythmia and the prevention of sudden cardiac death. This
article is part of a Special Issue entitled: TheCommunicating junctions, composition, structure and characteristics.l; CL, Cytoplasmic loop; Cx43,




+1 843 792 0664.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1831
2. Historical background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1832
3. Structure and function of the Cx43 carboxyl-terminus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1833
4. The role of ZO-1 interaction with Cx43 in regulation of GJ organization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1834
4.1. ZO-1 interaction with Cx43 and GJ internalization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1835
4.2. ZO-1 interaction with Cx43 and regulation of GJ size: in vitro studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1835
4.3. ZO-1 interaction with Cx43 and regulation of GJ size: in vivo studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1836
4.4. ZO-1 interaction with Cx43: GJ size and Cx43 level in cardiac disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1836
5. GJ targeting to the intercalated disk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1837
6. GJ lateralization in cardiac disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1838
7. Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1839
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1839
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18401. Introduction
Gap junctions (GJ)s provide for cytoplasmic continuity between
cells, permitting direct intercellular transmission of ions, secondmessengers, and other molecules less than 1 kDa [1–3]. Most
mammalian cells exhibit abundant GJ contacts with neighboring
cells, providing the basis for integrated networks within tissues. The
propagation of electrical activation in the heart is one of the more
widely known examples of tissue integration by an intercellular
network of GJs. That GJs have additional roles in tissue homeostasis
and dynamics is suggested by the near ubiquitous presence of GJs
between excitable and non-excitable cells in vertebrates.
The channels that are responsible for electrical coupling of
cardiomyocytes are composed of proteins encoded by the connexin
gene family [4]. Connexins comprise four transmembrane spanning
motifs, with both amino-(NT) and carboxyl-(CT) termini located on
the cytoplasmic side of the plasma membrane. Connexin subunits
1832 J.A. Palatinus et al. / Biochimica et Biophysica Acta 1818 (2012) 1831–1843form hexameric connexon oligomers, which trafﬁc to the membrane,
and dock with connexons from adjacent cells to form functional
intercellular channels [5] reviewed in Ref. [6]. Aggregation of docked
connexons results in the formation of the membrane organelle
responsible for cell-to-cell communication — the GJ plaque (Fig. 1).
The CT sequence is the site of greatest amino acid (aa) variability
between connexin isoforms [7] and thought to be the main regulatory
domain of most connexins. The connexin CT has roles in GJ assembly
and channel function, via numerous post-translational modiﬁcations
and protein–protein interactions (Fig. 2). These assignments within
the CT are also critical to governance of the trafﬁcking, size,
localization and turnover of GJs, as well as the level of intercellular
coupling mediated by the plaque. Disruption in the distribution or
extent of GJs is characteristic of various disease states, including slow
healing wounds in the skin, epileptic seizures in the brain and
arrhythmias in the heart. Mutations in Cx43 have been linked to the
inherited human disease oculodentodigital dysplasia (ODDD), though
interestingly relative to other domains of Cx43 there is a low
incidence of mutation in the CT [8].
Connexin 43 (Cx43) is a GJ protein commonly found in excitable
tissues in mammals, including humans [9–11]. The ventricular muscle
of the heart is particularly enriched for Cx43, where it localizes
preferentially to cardiomyocyte longitudinal termini — i.e. the
intercalated disk. Mislocalization of GJs from polarized distributions
at the intercalated disk and remodeling of Cx43 to the lateral surfaces
of cardiomyocytes have been noted in nearly every cardiac disease
state, and are correlatedwith the propensity of arrhythmia generation
in the affected tissues [12–18].
There are numerous informative and detailed surveys of the
literature on Cx43 remodeling and cardiac arrhythmic disease [9,19–
21]. Reviews on the structure, molecular biology and function of the
intercalateddisk in its role of providing aplatform for electromechanicalFig. 1. The gap junction and perinexus. Top) Schematic of gap junction plaque with
adjacent perinexus regulating hemichannel addition at the plaque edge. Bottom)
Immunoconfocal view of rat epicardial cells labeled for Cx43 in green and Cx43/ZO-1
interaction in red as labeled in situ by the Duolink protein–protein interaction assay.
Note that the extent of red signal in the perinexus exceeds that of the green
immunolabeled gap junction. For more information see Ref. [95].coupling between cardiomyocytes are also available for interested
readers [22–26].
Here, a perspective on regulation of GJ plaque size and localization
in the plasma membrane (sarcolemma) of ventricular working
myocardial cells will be provided. Emphasis in the review will be
placed on the role of the Cx43 CT, and in particular, the Cx43 CT-
interacting protein Zonula Occludens-1 (ZO-1). Where relevant, other
cell types, connexins, junctional molecules and interacting proteins
will be broached. Themechanisms determining normal GJ order in the
healthy myocardium and pathological disorder in the diseased heart
are a dual practical focus of this review. A working hypothesis is that
the establishment of orderly arrangements of GJ organization in the
sarcolemma is a key to stable propagation of electrical activation in
myocardial tissues. Breakdown of this order can lead to cardiac
conduction disturbance, arrhythmia and sudden death.2. Historical background
The initial evidence that GJs in the mammalian heart demonstrat-
ed high levels of spatial order came from the electron microscope.
Thin section electron microscopy localized large GJs at intercalated
disks, particularly at lateral segments of apposed sarcolemma within
disks [23,26–29]. Based on ultrastructural data, there were debates in
the literature as to the size of the largest GJs at the intercalated disk
[23,30], the resolution of which would await the advent of other
approaches, including immuno-confocal microscopy. Small, interpli-
cate GJs were also noted dispersed within the fascia adherens, the
extended adhesive junctional complexes responsible for stabilizing
mechanical interactions between cardiomyocytes [31,32].
Pioneering freeze fracture electron microscopy provided high
spatial and temporal resolution views of GJ aggregates in beating
myocardial tissues [33,34]. Aggregates of particles within GJs thought
to represent individual connexons, were revealed to occur in closely
packed arrays that were separated by particle-free aisles. Freeze
fracture studies of embryonic, neonatal and perinatal ventricle also
indicated the occurrence of developmental increases in the size of GJs
[35,36], suggestive that the differentiation of GJ organization in the
developing heart was in itself a progressive and regulated process.
The identiﬁcation of connexin gene sequences in the late 1980s
[37], including that encoding Cx43 [38] led to the advent of highly
speciﬁc antibodies. These antibodies, coupledwith powerful new light
microscopic techniques, such as laser scanning confocal microscopy
(LSCM), began to provide new views of the 3D order of GJs in the adult
and developing heart [39–42].
Conﬁrmation of the preferential localization of presumptive GJs at
intercalated disks using immunohistochemistry and Cx43 speciﬁc
antibodies was ﬁrst provided by Beyer and co-workers in 1989 [39].
Shortly thereafter it was demonstrated that Cx43 GJ substructure
showed further organization within the disk. Three-dimensional
reconstructions of en-face views of the termini of rat ventricular
cardiomyocytes from LSCM optical sections revealed circumferential
distributions of large immunolabeled GJs [40,44]. This spatial
conﬁguration was subsequently conﬁrmed to occur in the ventricles
of mice, humans and other mammals [40–45]. Quantitative compar-
ison of plaque size from immunoﬂuorescent labeling and freeze
fracture electron microscopy was among the approaches used to
validate that myocardial GJs were being correctly identiﬁed and
measured by the LSCM [41,46].
The distinct population of large GJs at the intercalated disk
circumference did not occur in the embryonic ventricle, or indeed
become fully manifest until quite late into postnatal development
[40,42,43,47]. Several immunoﬂuorescence studies indicated that
distributions of Cx43 GJs in the neonate were uniformly organized
around cardiomyocytes. But with subsequent maturational growth of
the heart there was a loss of these lateral contacts between
Fig. 2. The interacting proteins of the Cx43 carboxyl-terminus (CT). Amino acid sequence of human Cx43 from CT residues 234 to 382 labeled with sites of protein–protein
interaction. NMR structure of Cx43 was acquired by Sorgen and others [65] and obtained from the World Wide Protein Data Bank (PDB ID: 1R5S).
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of Cx43 immunolabeling at intercalated disks.
The culmination of this developmental process resulted in 60% or
greater of immunodetectable Cx43 at the disk in the ventricle of most
mammals [32]. It is thought that this polarization of GJs to the ends of
cardiomyocytes contributes to changes in conduction of the ventricle
from isotropic to more directional propagation of electrical impulse
along the longitudinal axis of myoﬁbers [48,49]. This being said,
mathematical modeling indicates that the postnatal increase in
cardiomyocyte size is probably a larger factor in the emergence of
directional propagation of cardiac action potentials than GJ distribu-
tion [50].
In 1991, studies of infarcted ventricular myocardium in humans
[51] and dogs [52] provided the ﬁrst indication that the pattern of
Cx43 GJs is profoundly altered in a narrow zone of surviving muscle
bordering the necrotic injury or scar — the infarct border zone. Since
publication of these results, a number of groups have conﬁrmed the
close linkage between GJ remodeling in the infarct border zone and
the propensity of ventricles to develop reentrant arrhythmias
[15,31,53–59]. Typical of infarct border zone remodeling is a loss of
GJs from the intercalated disk and redistribution of Cx43 to lateral
domains of sarcolemma: an arrangement reminiscent of the devel-
oping ventricle.
With the parallels between disease and development being raised,
an important distinction should be made. Cx43 shows homogenously
lateralized distributions between cells throughout the myocardial
tissues of the immature ventricle. By contrast, the lateralization of
Cx43 at the border zone of healed coronary infarcts in an adult heart
is an isolated and striking non-uniformity. Just a few cell layers
away from the border zone, Cx43 GJs can be seen to assume normaldistributions at intercalated disks. The remodeling of GJs in the
infarct border zone to lateralized distributions occurs relatively rapidly,
becoming notable within 24 h [60]. The extent to which Cx43 along
myocytes sides exists asGJs or connexons, or indeedwhether lateralized
Cx43 has channel function remains unclear.
The GJ is not the only element of the intercalated disk to show
progressive change over postnatal ventricular development. Adherens
junctions and desmosomal mechanical junctions also change from
lateral, side-by-side contacts between cardiomyocytes in the immature
ventricle to preferential accumulation at disks in the adult [47,61].
The accumulation of GJs to the intercalated disk notably lags behind
mechanical junctions, which assumemature localization at cardiomyo-
cyte termini signiﬁcantly earlier during postnatal development [61–63].
The important concept that intercalated disk assembly is a sequential
process will be discussed further in relation to differing hypotheses
regarding how GJs may be targeted to the intercalated disk.
3. Structure and function of the Cx43 carboxyl-terminus
Themain regulatory locus of Cx43 is the CT.While the CT sequence
distal to amino acid 258 appears dispensable for polarization to
cardiomyocyte termini [64], the Cx43 CT is required for proper
organization in the intercalated disk, as well as regulating the channel
responses to various chemical stimuli. Sorgen and others reported
that the CT of Cx43 is predominantly a random coil composed of 132
amino acids containing two helical domains and extending from the
cytoplasmic face of the membrane-docked channel [65] and in Figs. 1
and 2. This group further demonstrated that binding partners of the
Cx43 CT could signiﬁcantly alter its secondary structure. Importantly,
these structural alterations were observed at sites remote to the
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site of protein–protein interaction, but a platform through which
connexin-binding partners could interact and signal using this
sequence as an intermediary.
Proteins interacting with the Cx43 CT have been previously
reviewed by Giepmans in 2004 [66] and Herve et al. in 2007 [2]. An
updated survey of proteins interacting with the Cx43 CT is presented
in Fig. 2 and Table 1. The Cx43 CT–protein interactions of particular
note with respect to GJ channel assembly, regulation and trafﬁcking
are given particular attention. Fig. 2 shows the Cx43 CT sequence from
amino acid 234 to 382, with the known sites of interaction of several
Cx43 binding partners labeled. The consequence of CT-protein
interaction is additionally noted.
Table 1 lists the Cx43 CT binding partners shown in Fig. 2, with
additional information on site and functional consequences of
interaction. The table is organized in order of interaction site from
juxta-membrane to the distal terminus. Fig. 2 and Table 1 will serve as
a reference for the discussion of the CT binding partners that follows.
In the following sections we will address the role of these interactions
in regulation of Cx43 GJ organization. Extra attention will be given to
ZO-1, one of themost widely studied binding partners on the Cx43 CT.
In addition to participating in intermolecular interactions, the
Cx43 CT has been reported to dimerize under acidic conditions in
vitro [67]. This ability to dimerize suggests a potential for intramo-
lecular interactions in which a Cx43 CT may be capable of interacting
with itself or another domain of Cx43. The CT was proposed to
regulate GJ channels via a “ball and chain” mechanism [68] and
intramolecular interactions of this type appear to be involved in pH
sensitive gating [69,70]. Mimetic peptides based on the CT have also
been shown to interact with the cytoplasmic loop (CL) domain of
Cx43 and effect hemichannel function in a Xenopus oocyte model
[71]. Some of the ODDD mutations may inhibit the Cx43 CT–CL
intramolecular interaction [8]. Presently, it is unclear whether Cx43Table 1
Proteins interacting with the Cx43 carboxyl-terminus. Note: While some studies have cle
apparent that multiple kinases can phosphorylate the same serine residue under differen
phosphorylation event directly or via activation of another kinase. UKS = unknown signiﬁ
Interacting protein Amino acids Consequence
β-tubulin 234–262 Trafﬁcking and TGFβ
CaMKII S244 Phosphorylation, UK
Src SH2 Y247 Phosphorylation (di
MAPK/CaMKII S255 Phosphorylation, UK
CIP85 P253–P256 (*rat Cx43) Induce GJ turnover
CaMKII S257 Phosphorylation, UK
PKC S262 Phosphorylation, (re
Src SH2 Y265 Phosphorylation (di
V-Src SH3 274–287 SRC-Cx43 putative b
MAPK Y274 S279 S282 Phosphorylation (di
Nedd4 282–286 ubiquitination
CaMKII S296, S297, S306, S314, Phosphorylation, UK
CK1, CaMKII S325 S328, S330 Phosphorylation En
MMP-7 A357-I358 Potentially generate
PKA, CaMKII S364 Enhances channel a
PKA CaMKII S365 Phosphorylation gat
S368
PKC PKA S368 Phosphorylation (di
Decreased assembly
PKA, CaMKII S369 Increased Channel f
PKC S372 Phosphorylation, UK
PKA, 14-3-3 S373 Phosphorylation req
MMP-7 D379-L380 Potentially cleave PD
ZO-1-PDZ2 379–382 Reduced GJ size
Proteins with uncharacterized
binding sites
NOV/CCN3 Between 257 and 374 Reduced cell prolife
Caveolin-1/-2/-3 Binds whole C-terminus but not
D244 mutant
Indirect regulation o
Drebrin Unknown Cytoskeletal anchorCT intramolecular interactions contribute toGJ size control or cellular
distribution.4. The role of ZO-1 interaction with Cx43 in regulation of GJ
organization
A key step in understanding control of GJ organization in the heart
came with the identiﬁcation of the interaction of Cx43 with ZO-1
[72,73]. While there are numerous Cx43 CT binding partners, many of
which may be involved in regulating GJ size and cellular distribution,
few other interacting proteins have been studied as extensively as ZO-1
[11,74–79].
The second Postsynaptic density/Disks large/ZO-1 (PDZ) domain of
ZO-1 interacts directly with the distal extremity of the Cx43 CT [72,73].
Originally discovered in association with tight junctions [80], ZO-1 is
a member of the membrane-associated guanylate kinase (MAGUK)
family of proteins that function in protein targeting, signal transduction,
and determination of cell polarity [81,82]. MAGUKs, such as ZO-1,
synaptic protein PSD95 and the Drosophila tumor suppressor disks
large (dlg) are characterized by amino-terminal protein–protein bind-
ing motifs, including one or more PDZ domains.
Initial immunoprecipitation and yeast 2-hybrid studies showed that
a 4 amino acid PDZ-binding ligand at the extreme CT of Cx43 was
necessary for interactionwith the second of three PDZ domains on ZO-1
[72,73]. Ongoing work has indicated that the ZO-1-binding domain
comprises up to the CT-most 19 amino acids of Cx43 and this sequence
likely interacts with a ZO-1 dimer [83,84]. Structural studies have
demonstrated roles for ZO-1 binding in regulating Cx43 CT structural
conﬁrmation and signaling [65]. It is also now known that numerous
connexins interact with ZO-1 via a CT PDZ-binding sequence similar to
that of Cx43 [83,85–89]. A second MAGUK, ZO-2, has been reported to
interact with Cx43 in a cell-cycle dependent manner [90].arly identiﬁed certain serines and tyrosines as targets of speciﬁc kinases in vivo, it is
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When the interaction between Cx43 and ZO-1 was ﬁrst identiﬁed
in the late 1990s, it was proposed that its function was to stabilize GJs
in the plasma membrane. However, subsequent ﬁndings by a number
of groups, suggested that the view of ZO-1 as a passive scaffold at the
GJ was inadequate. Notably, ZO-1 has an actin-binding domain at its
CT, enabling linkage of GJs to cytoskeletal dynamics [91]. Consistent
with this ability to mediate linkage to actin, ongoing reports indicate
that the interaction between Cx43 and ZO-1 encompasses active
functions, including in GJ remodeling [74,92–103].
In the early 2000s, we published results showing that Cx43/ZO-1
interactions may be involved in the internalization of GJs [77,92]. The
approach was to demonstrate that ZO-1 and Cx43 association showed
an acute and conspicuous increase following collagenase dispersal of
cardiomyocytes from intact ventricles. Severs and others demonstrat-
ed in an earlier study that cardiomyocyte dissociation prompted mass
endocytosis of GJs, forming a stable population of vesicular annular
junctions within the cytoplasm [104]. We hypothesized in the 2002
study that a function of ZO-1 may have been to link Cx43 to actin-
based motors, and that this contributed to the rapid internalization of
GJs when cardiomyocytes were disaggregated from intact ventricular
muscle by collagenase.
Integral to this discussion is the parallel story of Cx43/Src interaction.
Src was identiﬁed as a potent inhibitor of Cx43 GJ communication in
1990 [105,106]. Tyrosine phosphorylationwas found to be a hallmark of
Src-mediated Cx43 inhibition, and it was demonstrated that Src
phosphorylates the Cx43 CT on residues Y247 and Y265 [107]. Saliently,
Toyofuku and co-workers later determined that phosphorylation
mediated by Src played a role in GJ communication deﬁcits in the
cardiomyopathic hamster heart [108]. The same group subsequently
demonstrated that Src binding and phosphorylation are mutually
exclusive to ZO-1 interaction with Cx43 [97]. In a ﬁnal twist, recent
datahas indicated thatSrc decreased interactionbetweenCx43andZO-1
by competitively binding to ZO-1 in the infarct border zone of a canine
coronary ligation model [109], with an associated loss of Cx43 from the
intercalated disk.
The above ﬁndings on Cx43, Src and ZO-1 indicated the occurrence
of complex interplay between the three proteins. Studies by Pointis,
Segretain and co-workers have provided further insight into this set of
interactions [74]. The aforementioned laboratories undertook their
work on association between Cx43 and ZO-1 during GJ internalization
in Sertoli and other cell lines [74]. In 2008, this group made the
observation that during a chemically induced GJ endocytosis, ZO-1
dissociated from one side of the GJ, but remained associated with the
other side of the plaque [98]. This loss of ZO-1 from a cytoplasmic face
of the GJ appeared to occur in response to competition for binding to
the Cx43 CT by Src. Asymmetric maintenance of ZO-1 on the other
plaque face culminated in focal concentration of the actin-binding
protein within the interior of endocytozed GJ vesicles. Interestingly,
the co-localization pattern reported by this group, wherein ZO-1
signals appeared to be contained with larger Cx43 particles, was
similar to that located at annular junctions in enzymatically-dispersed
cardiomyocytes [92]. More recent data from the French group shows
that internalization of annular junctions is dependent on the protein
dynamin2, which they demonstrate to interact with Cx43 during
plaque endocytosis [110].
Evidence that ZO-1 interaction with Cx43 is a mechanistically
necessary participant in GJ endocytosis came from papers examining
the response of Cx43 to inﬂammatory mediators. In 2007, van Zeijl et
al. reported that ZO-1 was required for the down-regulation of GJ
intercellular communication observed in response to endothelin-1
and thrombin-like agonists in Cx43-expressing Rat-1 cells [111]. In a
subsequent paper from the Falk group, using endothelial and HeLa
cells, it was demonstrated that thrombin and endothelin-1 inhibited
intercellular coupling via inducing rapid and acute internalization ofGJs [103]. Importantly, these authors showed that in the absence of
competent ZO-1 interaction with Cx43, internalization of GJs and
annular junction formation in response to treatment with the
inﬂammatory agonists did not occur.
Taken together the evidence from these studies suggested that ZO-1
interactionwith Cx43 is necessary for certain types of GJ internalization
processes. However, it is widely recognized that certain GJ endocytotic
events may not require ZO-1 [112,113]. In one instance, classical
clathrin-based mechanisms efﬁciently operate to mediate internaliza-
tion of GJs from the plasma membrane [112]. Furthermore, HeLa cells
expressing Cx43 rendered incompetent to interact with ZO-1 by a CT
GFP tag form large junctions without a signiﬁcant change in Cx43 half-
life, suggesting that in this context loss of the PDZ2 interaction does not
increase GJ turnover [100,101]. In ongoing work, our group ﬁnds that
ZO-1 binding to Cx43 CT can also direct actin-based force in the plane of
the plasma membrane, mediating the fusion and pulling apart of GJ
plaques [114].
Signiﬁcant questions remain regarding the molecular motors that
remodel Cx43 GJs. For example, in internalization events involving
ZO-1, it remains unknown how actin forces are imparted on the GJ.
Does it involve pulling or pushing of double-membrane GJs from the
plasma membranes of adjoined cells? What are the other linkage and
force generating constituents of these motors? Does the molecular
machinery that operates constitutively during GJ turnover differ from
that which operates during acute events such as in response to
ischemia, mechanical destabilization of cell–cell contacts or inﬂam-
matory cytokines?
4.2. ZO-1 interaction with Cx43 and regulation of GJ size: in vitro studies
Insight into a second role for ZO-1 at the GJ in the control of plaque
size was initiated from studies of Cx43–ZO-1 co-localization. In a 2002
paper we noted that the level of ZO-1 association with Cx43 in intact
ventricular myocardium was modest, with some GJ plaques at
intercalated disks demonstrating no detectable ZO-1 [92]. Immuno-
confocal microscopy of cultured neonatal rat ventricular cardiomyo-
cytes provided greater clarity of the association between the two
proteins than could be achieved in tissue sections of cardiac muscle
[115]. Confocal optical sectioning of monolayers of cardiomyocytes
revealed that ZO-1 preferentially localized at the edge of GJ plaques.
Having observed this peripheral accumulation of ZO-1 at the GJ
edge, the question arose as to what would happen if this association
was inhibited. We determined that treatment of neonatal rat
cardiomyocytes with a peptide mimetic of the Cx43 ZO-1-binding
domain decreased co-localization of ZO-1 at the edge of GJs and
increased plaque size [101]. This result was interpreted as implying
that ZO-1 interaction with Cx43 at the GJ edge may be acting to
constrain the extent of GJ channel aggregation.
Consistent with a role in inhibiting plaque size growth, it was also
noted that abnormally large GJs formed between HeLa cells
heterologously expressing a Cx43-GFP construct incompetent to
interact with ZO-1 [79] These large junctions were reduced to more
normal sizes when the cells were transduced by adenovirus expres-
sing wildtype Cx43 [100,101]. Subsequent work by Andrew Hunter in
the lab established that the Cx43-GFP GJs also had deﬁcits of ZO-1 at
the plaque edge, and that the reduction in plaque size caused by co-
expression of wildtype Cx43was accompanied by recruitment of ZO-1
to the edge of GJs [101].
It was also determined that the GJ size increase prompted by the
Cx43 CT peptide, did so via inhibiting the interaction of the second
PDZ domain of ZO-1 with Cx43 [101]. The reduction in interaction
mediated by the PDZ2-binding peptide in turn resulted in a shift
within the total pool of Cx43 protein in cells from detergent-soluble to
GJ-associated detergent-insoluble pools. Taken together, the results
indicated that ZO-1 controlled the rate at which Cx43 transitioned
from non-junctional to junctional pools of the protein [101].
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this function has been addressed [95]. The approach takenwas to use in
situ protein–protein interaction assays to further deﬁne the relationship
between Cx43 and ZO-1 in a HeLa cell model [95]. Using the Duo-link
assay to ﬂuorescently amplify Cx43 ZO-1 association, a previously
unknown zone of interaction proximal to the GJ edge was identiﬁed.
This sector, which we termed the Perinexus, appears to be the primary
site at which control of the transition of non-junctional connexons into
the junctional plaque occurs.
Based on the data reported, it was proposed that the mechanism of
ZO-1-mediated control of GJ size is via governing the connexon
hemichannel to GJ channel transition from the perinexus [95]. The
perinexal scaffold is envisaged as a sieve-like network containing ZO-1
that extends from the GJ edge. This network is part of amechanism that
regulates, but does not prevent, the ﬂow of connexons from
surrounding membrane available to dock with connexons from the
apposed cell (Fig. 1). In this manner, it was hypothesized that ZO-1
regulates a balance between connexon-mediated membrane per-
meance and GJ intercellular communication. Indeed, it was demon-
strated that the level of Cx43/ZO-1 interaction concomitantly and
inversely affected hemichannel-mediated dye uptake and GJ-mediated
cell-to-cell dye transfer [95].
The model of connexon ﬂow from the perinexus is consistent with
the widely held view that GJs are assembled from the outside edge of
the plaque inwards [116,117]. This was most notably illustrated in the
elegant study of Gaietta et al., in which pulse-chase labeling of
tetracysteine-tagged Cx43 with biarsenical compounds showed that
Cx43 accreted to the edge of GJs [117]. The new insight provided by
the Duolink assay is that the recruitment process draws from a pool of
non-junctional connexons located proximal to the GJ edge in the
perinexus [95].
The study also provided unexpected new data on the association
between actin, ZO-1 and Cx43 at GJs. Co-immunoprecipitation
demonstrated that ZO-1 interacted with both detergent soluble and
insoluble Cx43-containing connexons, but only those connexons
docked in the detergent insoluble fraction were also complexed with
actin [95]. These data correlated well with immunoﬂuorescenent data
showing preferential overlap of actin signal with Cx43/ZO-1 interac-
tion within the GJ as compared to the perinexus. At present, how this
partitioning of Cx43 interaction with the actin cytoskeleton is
regulated is unclear. Nonetheless, the linkage of actin to connexons
in the GJs, but less avid association with connexons in the perinexus,
may provide one explanation as to how ZO-1 appears to have dual
functions: One in the transmission of force to the GJ via tethering to
the actin cytoskeleton and the other in controlling the ﬂow of
connexons at the plaque perimeter.
One key question for ongoing work is the speciﬁcs of how perinexal
ZO-1 acts to regulate connexon recruitment. Another outstanding issue
is whether other connexins that interact with ZO-1, such as Cx40 [89]
andCx45 [86,118], exhibitmechanismsofGJ size control similar to those
of Cx43. There are also interesting related questions on whether
heteromeric and heterotypic partnering of connexins affect control of GJ
aggregation. In an example from the literature, coexpression of Cx43
with Cx45 in HeLa cells has been reported to decrease GJ size [119].
Characterization of CT interactions in cell models expressing and/or co-
expressing different connexin isoformsmay provide further insight into
the role of perinexus in regulating GJ organization.4.3. ZO-1 interaction with Cx43 and regulation of GJ size: in vivo studies
There is growing evidence that ZO-1 contributes to regulation of GJ
size in vivo. Delmar and co-workers determined that expression of a
CT-truncated Cx43 incompetent to interact directly with ZO-1
resulted in formation of abnormally large GJs in lateral sarcolemma
adjacent to the intercalated disk [64]. In patients with certain types ofcardiomyopathy, increased ZO-1 interaction with Cx43 was reported
to prompt attendant decreases in the abundance and size of GJs [11].
Recent studies from our lab have also elucidated how patterns of
ZO-1 interaction with Cx43 may generate the characteristically large
GJs ringing the intercalated disk. GJs at the periphery of the disks in
the rat ventricle were found to exhibit greater ZO-1 colocalization at
their inward, as compared to their outward facing edges [120].
Disruption of this asymmetric co-localization by expression of a ZO-1
truncation mutant resulted in loss of size distinction between GJs at
the peripheral edge of the intercalated disk versus those in the disk
interior.
Together with in vitro studies [95,101], it was proposed that the
larger size of GJs at the intercalated disk periphery resulted from
preferential accretion of connexons at the outward facing edge (i.e.,
ZO-1-lacking) of GJ plaques. Therefore, when connexon recruitment is
not regulated by the presence of a perinexal ZO-1 network, such as in
the case of GJs at the intercalated disk periphery [120] or between
Cx43-GFP expressing HeLa cells [100], plaques tend to grow larger.
4.4. ZO-1 interaction with Cx43: GJ size and Cx43 level in cardiac disease
While spatial remodeling of GJs is clearly associated with
arrhythmic disease, the functional signiﬁcance of changes in GJ size
to pathologic disturbance of conduction in the heart is less clear.
Maass and co-workers demonstrated that an increase in GJ size from
CT truncation of Cx43 was correlated with a propensity of acutely
injured hearts to develop inducible arrhythmias [121]. Whether this
effect is due to changes in GJ size or other phenomena associated with
CT truncation – such as changes in junctional conductance – remain
unclear. Conversely, Nick Severs group showed a decrease in GJ size in
ischemic and dilated cardiomyopathies [11]. Interestingly, in some
forms of severe epilepsy in humans, decreases in Cx43 GJ size have
been reported to accompany an increase in overall GJ area and
expression [122]. As is the case with cardiac arrhythmia, epilepsy is
characterized by the propagation of chaotic electrical activity.
In 2007, Yamada and co-workers found that ZO-1 and Cx43 levels
were reduced concomitant with a reduction in co-localization between
these two proteins at intercalated disks in humans at end-stage heart
failure [123]. Interestingly, although Cx43 levels were diminished, the
percentage of disks positive for Cx43 was not different from that of
controls. In a short report, Kostin described a similar diminution in ZO-1
in heart failure patients, but noted that Cx43 was decreased in
intercalated disks in which ZO-1 was also reduced [124]. Related
analyses were performed in 2007 on a rat model of right ventricular
hypertrophy. This study found increased GJ internalization and some
lateralization of Cx43, but in apparent contrast with the aforementioned
papers, no change in totalCx43 levels or the co-distributionof Cx43/ZO-1
in diseased hearts [125].
As touched upon in the ﬁrst paragraph of this section, Severs'
group in London performed an in-depth study on ventricular tissues
sampled from human patients in end-stage heart failure [11]. In line
with earlier results, these workers found that the abundance of Cx43
was signiﬁcantly reduced in patients compared to controls subjects.
Moreover, ZO-1 levels were increased at the intercalated disks in
these individuals, and ZO-1 levels showed a negative correlation with
Cx43 levels at disks. Furthermore, co-localization and co-immuno-
precipitation assays indicated that interaction between Cx43 and ZO-
1 was increased in these heart failure patients.
Recent data from the laboratories of Sorgen and Duffy on the border
zone of infarcted myocardium in a canine model of coronary occlusion
found that reductions in Cx43 level were associated with decreases in
Cx43/ZO-1 binding [109]. A novel interaction between activated Src and
ZO-1 showed a complementary increase in infarct border zone tissues.
Finally, in a report published in 2010, a rat model of pressure-overload
hypertrophy over an 8-week periodwas described inwhich Cx43 levels
initially increased, thendeclined back to control levels by 8 weeks [126].
Fig. 3. Two hypotheses for gap junction recruitment to intercalated disks. 1) Following
birth, mechanical junctions in the ventricle, including adherens junctions (red), undergo
rapid polarization to intercalated disks, while the emergence of polarized distributions of
Cx43 GJs (green) from lateral sarcolemma progresses on a slower time course. In Angst et
al. [61] itwasproposed that this pattern emerges asGJs tend tobe internalized (opengreen
circles) from lateral domains of sarcolemma during postnatal maturation, whereas those
GJs co-located with adherens junctions at disks are more liable to be retained in the
membrane. 2) Microtubules trafﬁc connexon hemichannels directly to the Adherens
junctions at the intercalated disk for direct assimilation into GJ plaques [142].
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serine 368 on its primary sequence. ZO-1 co-immunoprecipitationwith
Cx43 remained unchanged 2 weeks after pressure overload, but
declined slightly at 8 weeks.
In sum, the literature on relationships between Cx43/ZO-1 interac-
tion, GJ size, and Cx43 level in diseased myocardium is not amenable to
simple interpretation. Further reports of Cx43 remodeling in the
diseased ventricle include those by Goldﬁne et al. and Benes et al.
[127,128]. The different conclusions reached by different groupsmay be
grounded in part in the varying models that have been used. These
include two rodent models of hypertrophy, a canine ischemia model,
and samples from human patients at various stages of heart failurewith
differing disease etiologies. Lining up assays of speciﬁc microscopy and
biochemically based end-points with speciﬁc cardiac diseases and
disease stages may also be key considerations in uncovering mecha-
nism. Further work in this important area is evidently warranted.
5. GJ targeting to the intercalated disk
How GJs come to be targeted to and retained in the intercalated
disk is presently unknown. This being said, twomain hypotheses have
been proposed to explain how GJs assume polarized distributions at
cardiomyocyte termini. The ﬁrst hypothesis posits that polarization
results from intercalated disks having lower rates of loss or turnover
of GJs than other parts of the sarcolemma [61,63,129]. The second
hypothesis proposes that order is generated by direct trafﬁcking of
Cx43 to the intercalated disk via cytoskeletal pathways — most
notably via Cx43 CT interaction with microtubules. The two
propositions are not mutually exclusive and indeed, when eventually
understood, the actual mechanism may embody aspects of both.
Axiomatic to the ﬁrst hypothesis, is that Ca2+-dependent adhesion
junctions (adherens junctions and desmosomes) provide mechani-
cally stable domains of sarcolemma, within which GJs are less rapidly
turned over. The intercalated disk contains high concentrations of
adherens junctions and desmosomes. As such, in this model GJs would
tend to be preserved in or near disks in the active tissues of the
beating heart. Conversely, GJs in lateral domains of sarcolemmawould
be mechanically destabilized at higher rates, being more susceptible
to shearing stress at lateral interfaces between contracting muscle
cells.
The GJ turnover model was ﬁrst proposed based on descriptive
studies of postnatal maturation of the rat and dog heart [61]. During
cardiac maturational growth it was observed that the distribution of
GJs displayed a transient dissociation from those regions of sarco-
lemma exhibiting the greatest concentrations of cell–cell adhesion
junctions. This lack of GJ-mechanical junction association resulted
from GJs accruing from lateral sarcolemma to the intercalated disk
more slowly than the bulk of adherens junctions and desmosomal
contacts between cells (Fig. 3). In rats, the majority of both classes of
adhesion junctions (i.e., N60%) become polarized to the intercalated
disk between 10 and 20 days following birth [61]. By contrast, the
rodent is full grown at 90 postnatal days before themajority of Cx43 is
lost frommyocyte sides and immunolabeling in the disk matches that
of adherens or desmosomal junctions.
Peters et al., found that humans display a similarly extended time
course of intercalated disk formation, with lateralized GJs still apparent
in children up to 6 years of age [43]. The multi-year time course for
establishing polarized distributions of GJs is orders of magnitude slower
than theGJ trafﬁcking (b5 min) kinetics of Cx43. Additionally, thesedata
suggest that over extended periods of time (e.g., such as that occurring
over mammalian postnatal development), small deviations in turnover
of plaques between disk and lateral sarcolemma could generate large
differences in GJ abundance between these domains of membrane.
Electron microscopy of ventricle from normal adult mammals has
indicated that internalized or annular GJs are extremely rare [23,125].
However, a conspicuous increase in the frequency of annular GJs hasbeen described from ultrastructural studies of immature human [43],
rabbit [130], and dog [131] ventricle. Importantly, Mühlfeld and Richter
found that annular GJ numbers increased sharply between birth, 5 and
14 postnatal days in the rat [132]. The timing of this postnatal uptick in
internalizationwouldbe consistentwithGJ stabilitybeingdependenton
proximity to mechanical junctions, as it coincides with the develop-
mental phase in this species within which the sarcolemmal distribution
of adhesion junctions shows greatest dissociation from that of GJs [61].
Work in vitro and in vivo provides further support for the
dependence of GJ spatial distribution on that of adhesion junctions
between ventricularmyocardial cells. In a study using aligned cultures
of neonatal rat ventricular cardiomyocytes, Matsuda et al. recapitu-
lated the maturational dissociation of GJs and adherens junctions,
showing that polarization of Cx43 to cell termini was preceded by and
required the localization of N-cadherin at intercalated disks [133].
Consistent with biomechanics having a determinative role in the
differentiation of the intercalated disk, levels of expression and initial
localization of N-cadherin to cardiomyocyte termini have been
reported to be dependent on the conﬁguration of active mechanical
stress and strain [134–138].
Direct evidence of the requirement for stable cell–cell adhesion
junctions in GJ stability has been provided in experiments in which a
dominant negative N-cadherin was expressed in cultured cardiomyo-
cytes. This mutant N-cadherin prompted loss of Cx43 from the
sarcolemma and disruption of GJ contacts between cardiomyocyte
pairs [139]. In line with these in vitro studies, Luo and Radice showed
that cardiac-speciﬁc knockoutof theN-cadherin gene in transgenicmice
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that expression of a dominant negative disruptor of adherens junctions
in the postnatal rat ventricle leads to increases in lateralized GJs and
complementary decreases in Cx43 at intercalated disks [120] — results
consistentwith adhesion junctions being necessary for establishing and
maintaining normal GJ organization.
In the second hypothesis, targeting of Cx43 GJs to the intercalated
disk is proposed to involve trafﬁcking via microtubules. Falk, Giepmans
and colleagues demonstrated that the CT of Cx43 could directly interact
with β-tubulin and based on this interaction, it was proposed that
microtubules trafﬁcked connexins directly to the GJ [141]. Subsequent
work provided evidence that Cx43 targeting to the plasma membrane
involved delivery of connexons to N-cadherin complexes at the plus
ends of microtubules [142]. In this respect it is notable that N-cadherin,
β-catenin and Cx43 have been reported to co-immunoprecipitate as
part of a multi-protein complex [143].
Intercalated disks are enriched with N-cadherin — the Ca2+
dependent cell adhesion molecule found in cardiac adherens junctions.
It therefore follows that Cx43 should accumulate preferentially at sites
of N-cadherin enrichment where microtubules tether, such as the
intercalated disk. Further support for this trafﬁcking-based model has
come frommore recentwork from Shaw's group inwhich it was shown
thatbothCx43and themicrotubulebindingprotein EB1were decreased
at the intercalated disk of patientswith ischemic cardiomyopathy [144].
This observation was associated with a decreased localization of
microtubules at adherens junctions and decreased Cx43 trafﬁcking to
the disk.
Experiments utilizing the expression of a truncated Cx43 raise some
considerations for interpreting the role of microtubules in trafﬁcking of
connexins toGJs. It has been reported that amino acids 234 to 262 of the
Cx43 CT contain the necessary and sufﬁcient sequences to mediate
interaction with β-tubulin [141,145]. As outlined previously in this
review, a CT-truncation of Cx43 has been expressed in transgenic mice
[64]. This CT mutant was truncated from amino acid 258 and
presumably able to interact with microtubules normally, as it retained
a consensus microtubule-binding domain. The Cx43 mutant protein
accumulated at cardiomyocyte termini and formed functional GJs in this
transgenic. However, the structure of intercalated disks of mice
expressing the truncated Cx43 was disturbed, with GJs being located
in domains of sarcolemma lateral to, but not within the body of the disk
proper.Moreover, the GJs that formed in these domainswere unusually
large and showed abnormal associations with ZO-1, N-cadherin and
desmosomal proteins.
Taken together, the data suggest thatmicrotubule trafﬁckingmay be
necessary for general localization of Cx43 at adherens junction-rich
regions of sarcolemma. However, these cytoskeletal elements may not
be sufﬁcient tomaintain Cx43 distribution at the intercalated disk long-
term. Additional microtubule independent CT-interactions, or at least
Cx43 CT-interactions distal to the presumptive microtubule-binding
domainmay be required for normal GJ-adherens junction conﬁguration
within the disk.
Moreover, consonant with the ﬁrst hypothesis, numerous lines of
evidence support the concept of a hierarchical dependence of GJ pattern
and stability on the formation and distribution of adherens junctions.
The role of this relationship in establishing the cellular pattern GJ
connections may be particularly important in early postnatal life when
adherens junctions anddesmosomesundergo their rapidpolarization to
cardiomyocyte termini in response to changes in mechanical activity
followingbirth. This hierarchy is probably also evolutionarily conserved,
or at least been converged upon by other species, as cadherin junctions
have been reported necessary for membrane retention of innexins, the
genetically unrelated GJ proteins of invertebrates [146].
Proper localization of cardiac GJs in the physiologic state appears to
be ultimately determined by Ca2+-dependent adhesion junctions,
independent of whether GJ stability or targeting by microtubules
individually or jointly determine the pattern. Subsequent regulation ofGJs via protein–protein interaction and post-translational modiﬁcation
seems likely to be downstream of this requirement. A hypothetical
model for how GJs assume localization at the intercalated disk that
distils results from various studies is provided in Fig. 3.
Questions remain as to if, how and when the different processes
hypothesized in the model might act. Given that targeting GJs to the
intercalated disk occurs over the entire course of postnatal develop-
ment, it is conceivable that separate mechanisms may contribute at
differing phases or time scales. There are also speciﬁc outstanding
matters of interest. For example, the molecular mechanism responsible
for the spike in GJ internalization during early postnatal life remains to
be characterized. Cardiac-speciﬁc expression inmouse of a Cx43mutant
protein missing the consensus CT microtubule-binding domain could
provide useful insight into the role of trafﬁcking in the differentiation of
the intercalated disk.
6. GJ lateralization in cardiac disease
GJ order in the healthymyocardium and pathological disorder in the
diseased ventricle appear to show similarities. As has already been
broached, in disease GJs often assume lateral distributions that are
independent of intercalated disks. The lateralization of Cx43 observed in
many pathological scenarios is reminiscent of arrangements observed
during maturational growth of the ventricle. This remodeling of GJ
contacts in disease is thought responsible for heterogeneities in
electrotonic coupling that generate tissue substrates for re-entrant
arrhythmias.
In a further notable parallel to postnatal maturation, a number of
studies of experimental and clinical cardiomyopathies have shown that
Cx43 distribution dissociates from that of N-cadherin [147–151] or
desmosomal proteins [152,153]. In this pathological recapitulation of
developmental patterns in the adult, cell–cell adhesion junctions appear
to remain prominently localized at the intercalated disk, whereas Cx43
distributes to lateral sarcolemma (Fig. 4). Also similar to the situation
observed during postnatal growth, endocytozed GJs have been reported
to demonstrate an increase in frequency in some of these pathologies
[149,150,153].
Mutations of desmosomal proteins have been identiﬁed in a number
of rare arrhythmic cardiomyopathies including arrhythmic right
ventricular cardiomyopathy, Carvajal syndrome and Naxos disease
[154–157]. Disruption of mechanical junctions in these syndromes has
been noted to be associated with a loss and lateralization of Cx43 in
ventricular muscle [158,159]. The fact that the normal order of the
intercalated disk can also be disrupted by mutations in components of
desmosomal junctions [160,161], reinforces the notion of a hierarchical
dependence of GJ stability on the normal function of mechanical
contacts between cardiomyocytes.
The kinases and phosphatases responsible for regulating Cx43 CT
phosphorylation have important roles in determiningGJ organization in
the sarcolemma in health and disease [97,98,162–166]. These Cx43-
interacting proteins, and the phosphorylation events that theymediate,
have potential in the development of anti-arrhythmia therapies
[167,168]. Phosphorylation of serine 372 and 373 destabilizes Cx43 CT
binding to the ZO-1 PDZ2 domain [169], with presumptive downstream
consequences for GJ size regulation. In another example with clinical
implications, Fishman and colleagues identiﬁed a mechanistic link
between casein kinase-phosphorylation of the Cx43 CT, and blunting of
pathological GJ remodeling, in a pressure overload-induced model of
cardiac hypertrophy [168].
Speciﬁc patterns of Cx43 phosphorylation appear to be associated
with the conferring of resistance to pathological lateralization of GJs. Ek-
Vitorin et al. reported that in response to transient ischemia, upregula-
tion of PKC-epsilon mediated phosphorylation of Cx43 CT at serine 368
resulted in retention of subpopulations of GJs at intercalated disks, even
as total Cx43 underwent remodeling to lateral cardiomyocyte surfaces
[170]. Similarly, Kardami and co-workers demonstrated that ischemic-
Fig. 4. Gap junctions and adhesion junctions in cardiac development and disease. Immunolabeling of Cx43 and cell–cell adhesion junctions in ventricular myocardium from various
reports are shown from normal (undiseased) adult, diseased adult, and normal postnatal ventricle demonstrate how arrangements of intercellular junctions seen in the still
developing postnatal heart are recapitulated in adult disease.While these ﬁgures have not beenmodiﬁed, the color tables have been adjusted such that Cx43 is consistently indicated
by green signal and Ca2+-dependent adhesion junctions are in red A. Normal Adult Human Left Ventricle from Smyth JW, Hong TT, Gao D, Vogan JM, Jensen BC, Fong TS, Simpson PC,
Stainier DY, Chi NC, Shaw RM. Limited forward trafﬁcking of connexin 43 reduces cell–cell coupling in stressed human andmousemyocardium. J Clin Invest, 120 (2010) 266–79 used
by permision of the American Society for Clinical Investigation. B. S. Kostin, S. Dammer, S. Hein, W.P. Klovekorn, E.P. Bauer, J. Schaper, Connexin 43 expression and distribution in
compensated and decompensated cardiac hypertrophy in patients with aortic stenosis, Cardiovasc Res, 62 (2004) 426–436 used by permision of Oxford University Press. C.
Reproduced from Sepp R, Severs Nj, Gourdie Rg, Altered Patterns Of Cardiac Intercellular Junction Distribution In Hypertrophic Cardiomyopathy, Heart, 76 (1996) 412–417 with
permission from BMJ publishing group. D. Reproduced from A. Nygren, M.L. Olson, K.Y. Chen, T. Emmett, G. Kargacin, Y. Shimoni, Propagation of the cardiac impulse in the diabetic rat
heart: reduced conduction reserve, J Physiol, 580 (2007) 543–560. With permission from John, Wiley and Sons. E. Postnatal rat demonstrates uniform Cx43 distribution at the lateral
membranes and the disk — taken from [61]. Note that in all cases of disease Cx43 is detected in lateral domains of sarcolemma. Scale bars A=2.5 μm, B–E=10 μm.
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tion of serines at positions 262 and 368, and inhibited Cx43
lateralization following an ischemic insult [171]. Studies that examined
cell-cycle regulation of Cx43 have shown that during S-phase GJ
assembly is decreased and is correlatedwith increased phosphorylation
of serine 368 [164]. Phosphorylation may also have effects on
intramolecular interaction between the Cx43 CT and CL [71] and the
targeting of Cx43 to the intercalated disk [64,168].
The Cx43 CT-interacting kinase PKC-ε also seems to have promise as
a therapeutic target. Dhein and colleagues determined that a short
peptide, AAP10, inhibited Cx43 dephosphorylation at the PKC-ε
consensus serine 368 and remodeling of GJs away from intercalated
disks following induction of ischemia in a rabbit model [172]. Our
laboratory has demonstrated that a peptidemimetic of the Cx43 CT can
activate PKC-ε phosphorylation in vitro. Treatment of cardiac injuries
with this peptide in amousemodel resulted in increases in the levels of
Cx43 at intercalated disks and consistent with experiments in vitro,
prompted serine 368 phosphorylation of Cx43 [173].
Interestingly, Matrixmetalloproteinase-7 (MMP-7) has been shown
capable of cleaving peptides from the extreme CT of Cx43 [174] (Fig. 2).
It is unclear at this point if this can occur physiologically, as MMP-7 is
canonically extracellular whereas the Cx43 CT in cytoplasmic. None-
theless, this interesting result points to the possibility that endogenous
Cx43 may itself be a source of bioactive cleavage products. Given the
data on the actions of synthetic peptides based on the Cx43 CT[95,101,173,175], any endogenously generated peptides of related
sequencewould have the potential to regulate GJ size and conﬁguration
in the sarcolemma via modulation of PKC-ε, ZO-1 and other interacting
proteins.
7. Concluding remarks
The Cx43 CT, through its protein–protein interactions and post-
translational modiﬁcations, plays a direct role in regulating Cx43 GJ
size, localization and sub-organization at the intercalated disk in the
developing and adult ventricle. The proper arrangement of Cx43 GJs at
the disk is critical to the maintenance of a stable cardiac rhythm and
further understanding of Cx43 CT interactions could provide new
paths for therapies that prevent arrhythmia and sudden cardiac death.
Exciting future work would usefully focus on further elucidating the
processes that result in perturbations of Cx43 localization and
function in disease. By identifying the network of Cx43-binding
partners, and understanding their dynamic patterns of interaction, a
fuller understanding of the molecular determinants of pathological GJ
remodeling will emerge.
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